Patients' perspectives on buprenorphine subcutaneous implant: a case series

Patients' perspectives on buprenorphine subcutaneous implant: a case series

Abstract Background Considering the enormous burden represented by the opioid use disorder (OUD), it is important to always consider, when implementing opioid agonist therapy (OAT), the potential impact on patient’s adherence, quality of life, and detoxification. Thus, the purpose of the study is to...

Full description

Bibliographic Details
Main Authors:	Claudio Pierlorenzi, Marco Nunzi, Sabino Cirulli, Giovanni Francesco Maria Direnzo, Lucia Curatella, Sandra Liberatori, Annalisa Pascucci, Edoardo Petrone, Generoso Ventre, Concettina Varango, Maria Luisa Pulito, Antonella Varango, Cosimo Dandolo, Brunella Occupati, Roberta Marenzi, Claudio Leonardi
Format:	Article
Language:	English
Published:	BMC 2024-04-01
Series:	Journal of Medical Case Reports
Subjects:	Buprenorphine implant Opioid agonist therapy Opioid use disorder Sublingual buprenorphine
Online Access:	https://doi.org/10.1186/s13256-024-04483-6

Similar Items

The experience of buprenorphine implant in patients with opioid use disorder: a series of narrative interviews
by: Pietro Scurti, et al.
Published: (2023-08-01)

Adapting low-dose buprenorphine induction to meet patient needs: A pilot study
by: Zoe A. Karavolis, et al.
Published: (2022-12-01)

Single high-dose buprenorphine for opioid craving during withdrawal
by: Jamshid Ahmadi, et al.
Published: (2018-12-01)

Buprenorphine Induction Using Microdosing for the Management of Opioid Use Disorder in Pregnancy
by: Neil B. Patel, et al.
Published: (2024-01-01)

Implementation of an education session on buprenorphine induction in the emergency department, a resident-led initiative
by: Cara Marie Borelli, et al.
Published: (2024-01-01)

Low barrier buprenorphine treatment for persons experiencing homelessness and injecting heroin in San Francisco
by: Jamie Carter, et al.
Published: (2019-05-01)

Transdermal buprenorphine for pain management in children
by: Giorgio Attinà, et al.
Published: (2021-09-01)

Withdrawal during outpatient low dose buprenorphine initiation in people who use fentanyl: a retrospective cohort study
by: Benjamin L. H. Jones, et al.
Published: (2024-04-01)

Patient’s perspective on early treatment retention in take home buprenorphine maintenance treatment- an explorative study from India
by: P. M, et al.
Published: (2021-04-01)

A qualitative examination of the current management of opioid use disorder and barriers to prescribing buprenorphine in a Canadian emergency department
by: David Wiercigroch, et al.
Published: (2021-04-01)

Epidural Naloxone to Prevent Buprenorphine Induced PONV
by: Ashok Jadon, et al.
Published: (2008-01-01)

Low-dose buprenorphine initiation during pregnancy: a case report
by: Shivania Reddy, BSc, et al.
Published: (2024-02-01)

Deuterated buprenorphine retains pharmacodynamic properties of buprenorphine and resists metabolism to the active metabolite norbuprenorphine in rats
by: Venumadhav Janganati, et al.
Published: (2023-05-01)

Transition From Full Mu Opioid Agonists to Buprenorphine in Opioid Dependent Patients—A Critical Review
by: Michael Soyka
Published: (2021-11-01)

Subarachnoidally administered hyperbaric morphine, buprenorphine, methadone, and 10% dextrose on cardiopulmonary function and behavior in horses
by: Cláudio Corrêa Natalini, et al.
Published: (2006-10-01)

Role of buprenorphine in acute postoperative pain
by: J. Alcázar-Castro, et al.
Published: (2016-07-01)

Sublingual Buprenorphine/Naloxone and Multi-Modal Management for High-Risk Chronic Pain Patients
by: Shane Kaski, et al.
Published: (2021-03-01)

Rural and urban differences in undersupply of buprenorphine provider availability in the United States, 2018
by: Kevin P. Conway, et al.
Published: (2022-01-01)

Sleep problems in opioid dependent patients maintained on buprenorphine
by: R. Tripathi, et al.
Published: (2021-04-01)

Population pharmacokinetics of buprenorphine and naloxone sublingual combination in Chinese healthy volunteers and patients with opioid use disorder: Model-based dose optimization
by: Meng Gu, et al.
Published: (2023-01-01)

Outpatient Microdose Induction with Transdermal Buprenorphine: A Case Series
by: Shannon Menard, et al.
Published: (2022-07-01)

Oxybutynin treatment for buprenorphine-naloxone-induced hyperhidrosis
by: Lindsay McCormack, BA, et al.
Published: (2021-04-01)

Patient-reported problems filling buprenorphine prescriptions and motivations for illicit use
by: Erin L. Winstanley, et al.
Published: (2022-12-01)

Prescribing Buprenorphine for Opioid Use Disorders in the ED: A Review of Best Practices, Barriers, and Future Directions
by: Cao SS, et al.
Published: (2020-10-01)

Predisposing, enabling and need factors of heroin addicts’ using prescribed methadone or buprenorphine for a year or longer: An exploratory study of drug treatment for heroin addicts in the Swedish welfare system
by: Nilsson Marcus Blom, et al.
Published: (2014-04-01)

The effectiveness of different singly administered high doses of buprenorphine in reducing suicidal ideation in acutely depressed people with co-morbid opiate dependence: a randomized, double-blind, clinical trial
by: Jamshid Ahmadi, et al.
Published: (2018-08-01)

Emergency department‐initiated buprenorphine protocols: A national evaluation
by: Clara Z. Guo, et al.
Published: (2021-12-01)

Physicians’ satisfaction with providing buprenorphine treatment
by: Hannah K. Knudsen, et al.
Published: (2019-08-01)

Real-World Dispensing of Buprenorphine in California during Prepandemic and Pandemic Periods
by: Yun Wang, et al.
Published: (2024-01-01)

Opioid withdrawal presenting as delirium and role of buprenorphine: A case series
by: Sourav Das, et al.
Published: (2017-01-01)

Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic
by: David Dadiomov, et al.
Published: (2022-06-01)

Transmucosal Buprenorphine in the Treatment of Dyspnea: Case Series and Review of the Literature
by: Fran?ois Blumenfeld-Kouchner, et al.
Published: (2021-01-01)

Hospitalist perspectives on buprenorphine treatment for inpatients with opioid use disorder
by: Megan K Reed, et al.
Published: (2022-12-01)

Patterns of use and adverse events reported among persons who regularly inject buprenorphine: a systematic review
by: Nikki Bozinoff, et al.
Published: (2022-10-01)

Rapid effect of a single-dose buprenorphine on reduction of opioid craving and suicidal ideation: A randomized, double blind, placebo-controlled study
by: Jamshid Ahmadi, et al.
Published: (2020-01-01)

Safety and Efficacy of Buprenorphine-Naloxone in Pregnancy: A Systematic Review of the Literature
by: Alice Ordean, et al.
Published: (2023-02-01)

Fentanyl but Not Morphine or Buprenorphine Improves the Severity of Necrotizing Acute Pancreatitis in Rats
by: Emese Réka Bálint, et al.
Published: (2022-01-01)

Factors That Affect Patient Attrition in Buprenorphine Treatment for Opioid Use Disorder: A Retrospective Real-World Study Using Electronic Health Records
by: Ker S, et al.
Published: (2021-10-01)

Association of chronic non-cancer pain status and buprenorphine treatment retention among individuals with opioid use disorder: Results from electronic health record data
by: William S. John, et al.
Published: (2022-06-01)

Post operative analgesia after incisional infiltration of bupivacaine v/s bupivacaine with buprenorphine
by: Tanu R Mehta, et al.
Published: (2011-01-01)